Status:
RECRUITING
Optimizing Treatment of Adhesive Small Bowel Obstruction
Lead Sponsor:
University of California, Los Angeles
Conditions:
Adhesive Small Bowel Obstruction
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Small bowel obstruction (SBO) is one of the most common causes of serious gastrointestinal disease in the US. Adhesion-related SBO (aSBO) is usually treated by the placement of a nasogastric tube (NGT...
Eligibility Criteria
Inclusion
- Male or female ≥18 years of age.
- Documentation of aSBO as evidenced by one or more clinical features meeting the following criteria: Nausea, emesis, abdominal pain, distended abdomen CT evidence of aSBO
Exclusion
- Pregnant, breastfeeding, or unwilling to practice birth control during participation in the study.
- Presence of a condition or abnormality that in the opinion of the investigator would compromise the safety of the patient or the quality of the data.
- Unstable angina or recent myocardial infarction (MI)/stroke within 6 months
- Nonadhesive SBO
- Paralytic Ileus
- Incarcerated hernia
- Fecal impaction
- Intra-abdominal malignancy Early aSBO within 4 weeks of a prior abdominal operation
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06182319
Start Date
January 1 2024
End Date
December 15 2025
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Los Angeles, David Geffen School of Medicine
Los Angeles, California, United States, 90024